These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 10850436)

  • 1. p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer.
    Husgafvel-Pursiainen K; Boffetta P; Kannio A; Nyberg F; Pershagen G; Mukeria A; Constantinescu V; Fortes C; Benhamou S
    Cancer Res; 2000 Jun; 60(11):2906-11. PubMed ID: 10850436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 and K-ras mutations in lung cancers from former and never-smoking women.
    Vähäkangas KH; Bennett WP; Castrén K; Welsh JA; Khan MA; Blömeke B; Alavanja MC; Harris CC
    Cancer Res; 2001 Jun; 61(11):4350-6. PubMed ID: 11389059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.
    Le Calvez F; Mukeria A; Hunt JD; Kelm O; Hung RJ; Tanière P; Brennan P; Boffetta P; Zaridze DG; Hainaut P
    Cancer Res; 2005 Jun; 65(12):5076-83. PubMed ID: 15958551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
    Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC
    Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 Mutations in lung cancer associated with residential radon exposure.
    Yngveson A; Williams C; Hjerpe A; Lundeberg J; Söderkvist P; Pershagen G
    Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):433-8. PubMed ID: 10350439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and spectrum of p53 mutations associated with smoking in breast cancer.
    Conway K; Edmiston SN; Cui L; Drouin SS; Pang J; He M; Tse CK; Geradts J; Dressler L; Liu ET; Millikan R; Newman B
    Cancer Res; 2002 Apr; 62(7):1987-95. PubMed ID: 11929815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer risk in nonsmokers and GSTM1 and GSTT1 genetic polymorphism.
    Malats N; Camus-Radon AM; Nyberg F; Ahrens W; Constantinescu V; Mukeria A; Benhamou S; Batura-Gabryel H; Bruske-Hohlfeld I; Simonato L; Menezes A; Lea S; Lang M; Boffetta P
    Cancer Epidemiol Biomarkers Prev; 2000 Aug; 9(8):827-33. PubMed ID: 10952100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer.
    Lee YJ; Cho BC; Jee SH; Moon JW; Kim SK; Chang J; Chung KY; Park IK; Choi SH; Kim JH
    J Clin Oncol; 2010 Jan; 28(3):487-92. PubMed ID: 20008630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma.
    Zhang ZF; Morgenstern H; Spitz MR; Tashkin DP; Yu GP; Hsu TC; Schantz SP
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1043-9. PubMed ID: 11045786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53 alterations in bladder tumors from arsenic and tobacco exposed patients.
    Moore LE; Smith AH; Eng C; DeVries S; Kalman D; Bhargava V; Chew K; Ferreccio C; Rey OA; Hopenhayn C; Biggs ML; Bates MN; Waldman FM
    Carcinogenesis; 2003 Nov; 24(11):1785-91. PubMed ID: 12919957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study.
    Wenzlaff AS; Cote ML; Bock CH; Land SJ; Schwartz AG
    Carcinogenesis; 2005 Feb; 26(2):395-401. PubMed ID: 15528218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental tobacco smoke and lung cancer among Chinese nonsmoking males: might adenocarcinoma be the culprit?
    Tse LA; Yu IT; Au JS; Yu KS; Kwok KP; Qiu H; Wong TW
    Am J Epidemiol; 2009 Mar; 169(5):533-41. PubMed ID: 19126588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County.
    Jiang X; Yuan JM; Skipper PL; Tannenbaum SR; Yu MC
    Cancer Res; 2007 Aug; 67(15):7540-5. PubMed ID: 17671226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis.
    Nelson HH; Christiani DC; Wiencke JK; Mark EJ; Wain JC; Kelsey KT
    Cancer Res; 1999 Sep; 59(18):4570-3. PubMed ID: 10493509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene.
    Butkiewicz D; Popanda O; Risch A; Edler L; Dienemann H; Schulz V; Kayser K; Drings P; Bartsch H; Schmezer P
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2242-6. PubMed ID: 15598786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer.
    Ahrendt SA; Chow JT; Yang SC; Wu L; Zhang MJ; Jen J; Sidransky D
    Cancer Res; 2000 Jun; 60(12):3155-9. PubMed ID: 10866304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of common XPD and XRCC1 variant alleles on p53 mutations in lung tumors.
    Hou SM; Ryk C; Kannio A; Angelini S; Fält S; Nyberg F; Husgafvel-Pursiainen K
    Environ Mol Mutagen; 2003; 41(1):37-42. PubMed ID: 12552590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
    Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
    Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer and past occupational exposure to asbestos. Role of p53 and K-ras mutations.
    Husgafvel-Pursiainen K; Karjalainen A; Kannio A; Anttila S; Partanen T; Ojajärvi A; Vainio H
    Am J Respir Cell Mol Biol; 1999 Apr; 20(4):667-74. PubMed ID: 10100998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.